Typicality: | 0.527 |
Saliency: | 0.271 |
for 5 years | 10 | temporal |
with a 3.5 year open extension | 10 | other |
afterward | 7 | temporal |
subject → receive → either placebo | 18 |
subject → receive → either a placebo | 3 |
subject → take → either placebo | 3 |
negative | neutral | positive |
0.104 | 0.831 | 0.064 |
Raw frequency | 24 |
Normalized frequency | 0.271 |
Modifier score | 1.000 |
Perplexity | 265.234 |